|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Melisi D and Budillon A: Pancreatic
cancer: Between bench and bedside. Curr Drug Targets. 13:729–730.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nistico P, Bissell MJ and Radisky DC:
Epithelial-mesenchymal transition: General principles and
pathological relevance with special emphasis on the role of matrix
metalloproteinases. Cold Spring Harb Perspect Biol. 4:pii: a011908.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaianigo N, Melisi D and Carbone C: EMT
and treatment resistance in pancreatic cancer. Cancers. 9:pii:
E122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rochman M, Malicet C and Bustin M:
HMGN5/NSBP1: A new member of the HMGN protein family that affects
chromatin structure and function. Biochim Biophys Acta. 1799:86–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji SQ, Yao L, Zhang XY, Li XS and Zhou LQ:
Knockdown of the nucleosome binding protein 1 inhibits the growth
and invasion of clear cell renal cell carcinoma cells in
vitro and in vivo. J Exp Clin Cancer Res. 31:222012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen P, Wang XL, Ma ZS, Xu Z, Jia B, Ren
J, Hu YX, Zhang QH, Ma TG, Yan BD, et al: Knockdown of HMGN5
expression by RNA interference induces cell cycle arrest in human
lung cancer cells. Asian Pac J Cancer Prev. 13:3223–3228. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su B, Shi B, Tang Y, Guo Z, Yu X, He X, Li
X, Gao X and Zhou L: HMGN5 knockdown sensitizes prostate cancer
cells to ionizing radiation. Prostate. 75:33–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang W, Zheng J, Yu T and Wang J:
Overexpression of microRNA-495 suppresses the proliferation and
invasion and induces the apoptosis of osteosarcoma cells by
targeting high-mobility group nucleosome-binding domain 5. Oncol
Rep. 38:1099–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao Y, Zhang L, Wei M, Jiang X and Jia D:
MicroRNA-409-3p represses glioma cell invasion and proliferation by
targeting high-mobility group nucleosome-binding domain 5. Oncol
Res. 25:1097–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weng M, Song F, Chen J, Wu J, Qin J, Jin T
and Xu J: The high-mobility group nucleosome-binding domain 5 is
highly expressed in breast cancer and promotes the proliferation
and invasion of breast cancer cells. Tumour Biol. 36:959–966. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gan Y, He L, Yao K, Tan J, Zeng Q, Dai Y,
Liu J and Tang Y: Knockdown of HMGN5 increases the chemosensitivity
of human urothelial bladder cancer cells to cisplatin by targeting
PI3K/Akt signaling. Oncol Lett. 14:6463–6470. 2017.PubMed/NCBI
|
|
13
|
Liu X, Ma W, Yan Y and Wu S: Silencing
HMGN5 suppresses cell growth and promotes chemosensitivity in
esophageal squamous cell carcinoma. J Biochem Mol Toxicol. 31:2017.
View Article : Google Scholar
|
|
14
|
Shi Z, Tang R, Wu D and Sun X: Research
advances in HMGN5 and cancer. Tumour Biol. 37:1531–1539. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.PubMed/NCBI
|
|
17
|
Peng L, Liu Z, Xiao J, Tu Y, Wan Z, Xiong
H, Li Y and Xiao W: MicroRNA-148a suppresses epithelial-mesenchymal
transition and invasion of pancreatic cancer cells by targeting
Wnt10b and inhibiting the Wnt/β-catenin signaling pathway. Oncol
Rep. 38:301–308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao Z, Xu X, Liu Y, Chao H, Lin C, Li Z,
You Y, Liu N and Ji J: CBX7 negatively regulates migration and
invasion in glioma via Wnt/β-catenin pathway inactivation.
Oncotarget. 8:39048–39063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamoto M and Hisaoka M:
Clinicopathological Implications of Wingless/int1 (WNT) signaling
pathway in pancreatic ductal adenocarcinoma. J UOEH. 38:1–8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
